Surgalign Holdings, Inc. provided revenue guidance for the year 2022. The company estimates it will report full year 2022 revenue of approximately $82.0 million.
Surgalign Holdings, Inc.
Equities
SRGA
US86882C2044
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
-5.63% | 28.92B | |
+27.63% | 8.15B | |
+26.15% | 4.27B | |
-30.37% | 2.53B | |
-8.96% | 1.63B | |
-18.87% | 1.41B | |
-34.19% | 1.14B | |
+5.14% | 904M | |
-41.37% | 838M |